Related Experiment Video
Updated: Apr 15, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
The immunoglobulin M-degrading enzyme of Streptococcus suis, IdeSsuis, is a highly protective antigen against
Jana Seele1, Lena-Maria Hillermann1, Andreas Beineke2
1Institute for Microbiology, Department of Infectious Diseases, University of Veterinary Medicine Hannover, Hannover, Germany.
Abstract:
Streptococcus suis (S. suis) is a major porcine pathogen causing meningitis, arthritis and several other pathologies. Recently, we identified a highly specific immunoglobulin M degrading enzyme of S. suis, designated IdeSsuis, which is expressed by various serotypes. The objective of this work was to access the immunogenicity and protective efficacy of a recombinant vaccine including IdeSsuis. Vaccination with rIdeSsuis elicited antibodies efficiently neutralizing the IgM protease activity. Importantly, 18 piglets vaccinated with rIdeSsuis alone or in combination with bacterin priming were completely protected against mortality and severe morbidity after S. suis serotype 2 challenge. In contrast, 12 of the 17 piglets either treated with the placebo or primed with the bacterin only, succumbed to S. suis disease. Immunity against IdeSsuis was associated with increased killing of S. suis wt in porcine blood ex vivo leading to a tenfold difference in the bacterial survival factor in blood of placebo-treated and rIdeSsuis-vaccinated piglets. In conclusion, the results of this study indicate that rIdeSsuis is a highly protective antigen in pigs.
Insights
A novel recombinant vaccine using Streptococcus suis's IgM degrading enzyme (IdeSsuis) protected piglets from disease. This IdeSsuis vaccine shows high efficacy against S. suis infections in pigs.
Area of Science:
- Veterinary Microbiology
- Immunology
- Vaccine Development
Background:
- Streptococcus suis is a significant swine pathogen causing severe diseases like meningitis and arthritis.
- A specific immunoglobulin M (IgM) degrading enzyme, IdeSsuis, has been identified in S. suis strains.
- The potential of IdeSsuis as a vaccine candidate against S. suis infections requires investigation.
Purpose of the Study:
- To evaluate the immunogenicity and protective efficacy of a recombinant IdeSsuis (rIdeSsuis) vaccine in pigs.
- To assess the impact of rIdeSsuis vaccination on S. suis survival in porcine blood.
Main Methods:
- Production and administration of recombinant IdeSsuis (rIdeSsuis) vaccine to piglets.
- Challenge with virulent S. suis serotype 2 and monitoring of clinical outcomes (mortality, morbidity).
- Measurement of anti-IdeSsuis antibodies and assessment of S. suis killing in porcine blood ex vivo.
Main Results:
- Vaccination with rIdeSsuis successfully elicited neutralizing antibodies against IdeSsuis.
- Piglets vaccinated with rIdeSsuis demonstrated complete protection against mortality and severe morbidity following S. suis challenge.
- rIdeSsuis vaccination significantly enhanced the killing of S. suis in porcine blood, reducing bacterial survival.
Conclusions:
- Recombinant IdeSsuis (rIdeSsuis) is a highly immunogenic and protective antigen in pigs.
- The rIdeSsuis vaccine offers a promising strategy for controlling Streptococcus suis infections in swine populations.
More Related Videos
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
09:26Identification of Antibacterial Immunity Proteins in Escherichia coli using MALDI-TOF-TOF-MS/MS and Top-Down Proteomic Analysis
Published on: May 23, 2021
Related Concept Videos
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Humoral Immune Responses
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Cell-mediated Immune Responses